Trademark: 88035450
Word
IMMUNOSCAPE
Status
Registered
Status Code
700
Status Date
Tuesday, April 28, 2020
Serial Number
88035450
Registration Number
6039731
Registration Date
Tuesday, April 28, 2020
Mark Type
4000
Filing Date
Thursday, July 12, 2018
Published for Opposition
Tuesday, February 11, 2020

Trademark Owner History
immunoscape Pte Ltd - Original Registrant

Classifications
42 Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features

Trademark Events
Sep 6, 2022
Teas Change Of Correspondence Received
Sep 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 28, 2020
Registered-Principal Register
Feb 11, 2020
Official Gazette Publication Confirmation E-Mailed
Feb 11, 2020
Published For Opposition
Jan 22, 2020
Notification Of Notice Of Publication E-Mailed
Jan 8, 2020
Approved For Pub - Principal Register
Jan 7, 2020
Teas/Email Correspondence Entered
Jan 7, 2020
Correspondence Received In Law Office
Dec 30, 2019
Teas Response To Suspension Inquiry Received
Dec 5, 2019
Notification Of Letter Of Suspension E-Mailed
Dec 5, 2019
Letter Of Suspension E-Mailed
Dec 5, 2019
Suspension Letter Written
Dec 3, 2019
Teas/Email Correspondence Entered
Dec 3, 2019
Correspondence Received In Law Office
Nov 22, 2019
Teas Response To Suspension Inquiry Received
Nov 20, 2019
Notification Of Inquiry As To Suspension E-Mailed
Nov 20, 2019
Inquiry To Suspension E-Mailed
Nov 20, 2019
Suspension Inquiry Written
Nov 19, 2019
Suspension Checked ¿ To Attorney For Action
Nov 12, 2019
Assigned To Lie
Apr 19, 2019
Teas Change Of Correspondence Received
Apr 18, 2019
Notification Of Letter Of Suspension E-Mailed
Apr 18, 2019
Letter Of Suspension E-Mailed
Apr 18, 2019
Suspension Letter Written
Apr 16, 2019
Teas/Email Correspondence Entered
Apr 15, 2019
Correspondence Received In Law Office
Apr 15, 2019
Teas Response To Office Action Received
Nov 8, 2018
Notification Of Non-Final Action E-Mailed
Nov 8, 2018
Non-Final Action E-Mailed
Nov 8, 2018
Non-Final Action Written
Oct 30, 2018
Assigned To Examiner
Jul 17, 2018
New Application Office Supplied Data Entered In Tram
Jul 16, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24